Holder of CRNC (CRNC) plans potential sale of 25,998 common shares

Rhea-AI Filing Summary

A holder of 25,998 shares of CRNC common stock has filed to potentially sell these shares through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned transaction has an aggregate market value of $229,507.74 and lists an approximate sale date of August 10, 2026 on NASDAQ.

The filing also references prior acquisitions of CRNC restricted stock from the issuer on October 1, 2025, covering grants of 2,753 and 23,245 shares.

Key Figures

Shares to be sold: 25,998 shares Aggregate market value: $229,507.74 Approximate sale date: 08/10/2026 +2 more

5 metrics

Shares to be sold 25,998 shares Planned sale of CRNC common stock under Form 144

Aggregate market value $229,507.74 Value of 25,998 CRNC shares covered by the notice

Approximate sale date 08/10/2026 Expected start date for selling CRNC shares

Restricted stock grant 1 2,753 shares CRNC restricted stock acquired from issuer on 10/01/2025

Restricted stock grant 2 23,245 shares CRNC restricted stock acquired from issuer on 10/01/2025

Key Terms

Form 144, Restricted Stock, aggregate market value, approximate sale date

4 terms

Form 144 regulatory

"A holder of 25,998 shares of CRNC common stock has filed to potentially sell"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"The filing also references prior acquisitions of CRNC restricted stock from the issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate market value financial

"The planned transaction has an aggregate market value of $229,507.74"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

approximate sale date financial

"lists an approximate sale date of August 10, 2026 on NASDAQ"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 04:38 PM Accepted by SEC EDGAR 08/10/2026 - 04:37 PM Learn about SEC filing dates

FAQ

What size CRNC common stock sale is indicated in this Form 144 filing?

The Form 144 indicates a potential sale of 25,998 shares of CRNC common stock with an aggregate market value of $229,507.74, to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services.

When is the approximate sale date for the CRNC shares in this Form 144?

The approximate sale date for the 25,998 CRNC shares is listed as August 10, 2026. This date reflects when the filer expects to begin selling shares, subject to market conditions and applicable rules.

Which broker is handling the planned CRNC share sale in this Form 144?

The planned sale of 25,998 CRNC shares is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

On which exchange are the CRNC shares in this Form 144 expected to trade?

The filing identifies NASDAQ as the exchange for the planned sale of 25,998 CRNC common shares, indicating that any transactions under this Form 144 would occur on that market.

What restricted stock grants are referenced in the CRNC Form 144?

The filing cites CRNC restricted stock acquired from the issuer on October 1, 2025, including blocks of 2,753 and 23,245 shares. These grants form part of the securities history disclosed in the notice.

Does the CRNC Form 144 guarantee that the 25,998 shares will be sold?

A Form 144 does not guarantee a sale; it notifies regulators of an intent to sell up to 25,998 CRNC shares. Actual sales can differ based on market conditions and holder decisions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25998	229507.74	45230257	08/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock	Issuer			2753	10/01/2025	Not Applicable
Common	10/01/2025	Restricted Stock	Issuer			23245	10/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)